nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorouracil—MTHFR—cervical cancer	0.609	1	CbGaD
Fluorouracil—ABCG2—Topotecan—cervical cancer	0.18	1	CbGbCtD
Fluorouracil—UPP2—renal system—cervical cancer	0.00545	0.0479	CbGeAlD
Fluorouracil—UMPS—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.00355	0.0584	CbGpPWpGaD
Fluorouracil—UMPS—uterine cervix—cervical cancer	0.0033	0.029	CbGeAlD
Fluorouracil—UPP2—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.0033	0.0543	CbGpPWpGaD
Fluorouracil—UPP1—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.0033	0.0543	CbGpPWpGaD
Fluorouracil—UMPS—decidua—cervical cancer	0.00315	0.0277	CbGeAlD
Fluorouracil—UPP1—uterine cervix—cervical cancer	0.00303	0.0266	CbGeAlD
Fluorouracil—Myelosuppression—Topotecan—cervical cancer	0.00296	0.0819	CcSEcCtD
Fluorouracil—UPP1—decidua—cervical cancer	0.00289	0.0254	CbGeAlD
Fluorouracil—UMPS—uterus—cervical cancer	0.00275	0.0242	CbGeAlD
Fluorouracil—UPP1—endometrium—cervical cancer	0.00274	0.0241	CbGeAlD
Fluorouracil—UPP1—mammalian vulva—cervical cancer	0.00265	0.0233	CbGeAlD
Fluorouracil—UPP1—uterus—cervical cancer	0.00252	0.0222	CbGeAlD
Fluorouracil—UMPS—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.00248	0.0409	CbGpPWpGaD
Fluorouracil—UMPS—female reproductive system—cervical cancer	0.00247	0.0217	CbGeAlD
Fluorouracil—DPYD—uterine cervix—cervical cancer	0.00246	0.0216	CbGeAlD
Fluorouracil—DPYD—decidua—cervical cancer	0.00234	0.0206	CbGeAlD
Fluorouracil—UPP1—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.00231	0.038	CbGpPWpGaD
Fluorouracil—UPP2—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.00231	0.038	CbGpPWpGaD
Fluorouracil—Febrile neutropenia—Topotecan—cervical cancer	0.00231	0.0638	CcSEcCtD
Fluorouracil—DPYD—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.00229	0.0376	CbGpPWpGaD
Fluorouracil—PPAT—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.00229	0.0376	CbGpPWpGaD
Fluorouracil—UPP1—female reproductive system—cervical cancer	0.00227	0.0199	CbGeAlD
Fluorouracil—UMPS—female gonad—cervical cancer	0.00225	0.0198	CbGeAlD
Fluorouracil—UMPS—vagina—cervical cancer	0.00224	0.0197	CbGeAlD
Fluorouracil—PPAT—uterine cervix—cervical cancer	0.00213	0.0187	CbGeAlD
Fluorouracil—UPP1—female gonad—cervical cancer	0.00206	0.0181	CbGeAlD
Fluorouracil—UPP1—vagina—cervical cancer	0.00205	0.018	CbGeAlD
Fluorouracil—DPYD—uterus—cervical cancer	0.00205	0.018	CbGeAlD
Fluorouracil—Heartburn—Topotecan—cervical cancer	0.00201	0.0558	CcSEcCtD
Fluorouracil—PPAT—endometrium—cervical cancer	0.00193	0.0169	CbGeAlD
Fluorouracil—PPAT—mammalian vulva—cervical cancer	0.00186	0.0164	CbGeAlD
Fluorouracil—DPYD—female gonad—cervical cancer	0.00168	0.0147	CbGeAlD
Fluorouracil—TYMP—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.00163	0.0268	CbGpPWpGaD
Fluorouracil—DPYD—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.0016	0.0263	CbGpPWpGaD
Fluorouracil—PPAT—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.0016	0.0263	CbGpPWpGaD
Fluorouracil—PPAT—female reproductive system—cervical cancer	0.00159	0.014	CbGeAlD
Fluorouracil—Extravasation—Topotecan—cervical cancer	0.00159	0.044	CcSEcCtD
Fluorouracil—PPAT—female gonad—cervical cancer	0.00145	0.0128	CbGeAlD
Fluorouracil—UMPS—lymph node—cervical cancer	0.00145	0.0127	CbGeAlD
Fluorouracil—PPAT—vagina—cervical cancer	0.00144	0.0127	CbGeAlD
Fluorouracil—TYMP—uterine cervix—cervical cancer	0.00142	0.0125	CbGeAlD
Fluorouracil—SLC29A1—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.00141	0.0233	CbGpPWpGaD
Fluorouracil—TYMP—decidua—cervical cancer	0.00136	0.0119	CbGeAlD
Fluorouracil—SLC22A7—renal system—cervical cancer	0.00133	0.0117	CbGeAlD
Fluorouracil—UPP1—lymph node—cervical cancer	0.00133	0.0117	CbGeAlD
Fluorouracil—TYMP—endometrium—cervical cancer	0.00129	0.0113	CbGeAlD
Fluorouracil—Rash maculo-papular—Topotecan—cervical cancer	0.00126	0.0349	CcSEcCtD
Fluorouracil—TYMP—mammalian vulva—cervical cancer	0.00125	0.011	CbGeAlD
Fluorouracil—TYMS—uterine cervix—cervical cancer	0.00122	0.0107	CbGeAlD
Fluorouracil—Sepsis—Topotecan—cervical cancer	0.0012	0.0333	CcSEcCtD
Fluorouracil—ABCC5—uterine cervix—cervical cancer	0.00119	0.0105	CbGeAlD
Fluorouracil—TYMP—uterus—cervical cancer	0.00119	0.0104	CbGeAlD
Fluorouracil—TYMP—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.00114	0.0188	CbGpPWpGaD
Fluorouracil—ABCC5—decidua—cervical cancer	0.00114	0.01	CbGeAlD
Fluorouracil—TYMS—endometrium—cervical cancer	0.00111	0.00972	CbGeAlD
Fluorouracil—TYMP—Bladder Cancer—FGFR3—cervical cancer	0.0011	0.018	CbGpPWpGaD
Fluorouracil—SLC29A1—uterine cervix—cervical cancer	0.0011	0.00963	CbGeAlD
Fluorouracil—DPYD—lymph node—cervical cancer	0.00108	0.00947	CbGeAlD
Fluorouracil—MTHFR—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.00108	0.0177	CbGpPWpGaD
Fluorouracil—TYMS—mammalian vulva—cervical cancer	0.00107	0.0094	CbGeAlD
Fluorouracil—TYMP—female reproductive system—cervical cancer	0.00107	0.00938	CbGeAlD
Fluorouracil—Dermatitis bullous—Topotecan—cervical cancer	0.00105	0.0292	CcSEcCtD
Fluorouracil—SLC29A1—decidua—cervical cancer	0.00104	0.00918	CbGeAlD
Fluorouracil—TYMS—E2F transcription factor network—YY1—cervical cancer	0.00103	0.017	CbGpPWpGaD
Fluorouracil—Lethargy—Topotecan—cervical cancer	0.00103	0.0284	CcSEcCtD
Fluorouracil—SLC29A1—renal system—cervical cancer	0.00103	0.00901	CbGeAlD
Fluorouracil—MTHFR—female reproductive system—cervical cancer	0.001	0.00882	CbGeAlD
Fluorouracil—SLC29A1—endometrium—cervical cancer	0.000992	0.00871	CbGeAlD
Fluorouracil—SLC29A1—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.000988	0.0163	CbGpPWpGaD
Fluorouracil—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000988	0.0162	CbGpPWpGaD
Fluorouracil—TYMP—female gonad—cervical cancer	0.000971	0.00854	CbGeAlD
Fluorouracil—TYMP—vagina—cervical cancer	0.000966	0.00848	CbGeAlD
Fluorouracil—SLC29A1—mammalian vulva—cervical cancer	0.000959	0.00843	CbGeAlD
Fluorouracil—Cardiac arrest—Topotecan—cervical cancer	0.000957	0.0265	CcSEcCtD
Fluorouracil—ABCC3—decidua—cervical cancer	0.000955	0.00839	CbGeAlD
Fluorouracil—UMPS—Fluoropyrimidine Activity—TP53—cervical cancer	0.000943	0.0155	CbGpPWpGaD
Fluorouracil—ABCC3—renal system—cervical cancer	0.000938	0.00824	CbGeAlD
Fluorouracil—ABCC5—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.000936	0.0154	CbGpPWpGaD
Fluorouracil—PPAT—lymph node—cervical cancer	0.000933	0.0082	CbGeAlD
Fluorouracil—TYMS—female reproductive system—cervical cancer	0.000916	0.00805	CbGeAlD
Fluorouracil—SLC29A1—uterus—cervical cancer	0.000914	0.00803	CbGeAlD
Fluorouracil—MTHFR—female gonad—cervical cancer	0.000913	0.00803	CbGeAlD
Fluorouracil—UPP1—Fluoropyrimidine Activity—TP53—cervical cancer	0.000876	0.0144	CbGpPWpGaD
Fluorouracil—UPP2—Fluoropyrimidine Activity—TP53—cervical cancer	0.000876	0.0144	CbGpPWpGaD
Fluorouracil—TYMS—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.000834	0.0137	CbGpPWpGaD
Fluorouracil—TYMS—female gonad—cervical cancer	0.000833	0.00732	CbGeAlD
Fluorouracil—TYMS—vagina—cervical cancer	0.000828	0.00728	CbGeAlD
Fluorouracil—Pancytopenia—Topotecan—cervical cancer	0.000826	0.0229	CcSEcCtD
Fluorouracil—SLC29A1—female reproductive system—cervical cancer	0.000821	0.00722	CbGeAlD
Fluorouracil—ABCC5—female gonad—cervical cancer	0.000814	0.00715	CbGeAlD
Fluorouracil—ABCC5—vagina—cervical cancer	0.000809	0.00711	CbGeAlD
Fluorouracil—SLC22A7—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.000805	0.0132	CbGpPWpGaD
Fluorouracil—Pneumonia—Topotecan—cervical cancer	0.00078	0.0216	CcSEcCtD
Fluorouracil—Infestation—Topotecan—cervical cancer	0.000776	0.0215	CcSEcCtD
Fluorouracil—Infestation NOS—Topotecan—cervical cancer	0.000776	0.0215	CcSEcCtD
Fluorouracil—ABCC4—renal system—cervical cancer	0.000774	0.0068	CbGeAlD
Fluorouracil—Neuropathy peripheral—Topotecan—cervical cancer	0.00076	0.0211	CcSEcCtD
Fluorouracil—Stomatitis—Topotecan—cervical cancer	0.000756	0.0209	CcSEcCtD
Fluorouracil—ABCC3—female reproductive system—cervical cancer	0.000751	0.0066	CbGeAlD
Fluorouracil—SLC29A1—female gonad—cervical cancer	0.000747	0.00657	CbGeAlD
Fluorouracil—SLC29A1—vagina—cervical cancer	0.000743	0.00653	CbGeAlD
Fluorouracil—Epistaxis—Topotecan—cervical cancer	0.000732	0.0203	CcSEcCtD
Fluorouracil—CYP2A6—vagina—cervical cancer	0.000725	0.00637	CbGeAlD
Fluorouracil—Haemoglobin—Topotecan—cervical cancer	0.0007	0.0194	CcSEcCtD
Fluorouracil—Rhinitis—Topotecan—cervical cancer	0.000698	0.0193	CcSEcCtD
Fluorouracil—Haemorrhage—Topotecan—cervical cancer	0.000696	0.0193	CcSEcCtD
Fluorouracil—Hypoaesthesia—Topotecan—cervical cancer	0.000693	0.0192	CcSEcCtD
Fluorouracil—Pharyngitis—Topotecan—cervical cancer	0.000691	0.0191	CcSEcCtD
Fluorouracil—ABCC3—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.00069	0.0114	CbGpPWpGaD
Fluorouracil—ABCC4—uterus—cervical cancer	0.00069	0.00606	CbGeAlD
Fluorouracil—ABCC3—female gonad—cervical cancer	0.000684	0.00601	CbGeAlD
Fluorouracil—TYMS—One Carbon Metabolism—MTHFR—cervical cancer	0.000665	0.0109	CbGpPWpGaD
Fluorouracil—ABCC5—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.000655	0.0108	CbGpPWpGaD
Fluorouracil—ABCC4—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.000649	0.0107	CbGpPWpGaD
Fluorouracil—TYMP—lymph node—cervical cancer	0.000625	0.00549	CbGeAlD
Fluorouracil—ABCC4—female reproductive system—cervical cancer	0.00062	0.00545	CbGeAlD
Fluorouracil—Alopecia—Topotecan—cervical cancer	0.000615	0.017	CcSEcCtD
Fluorouracil—DPYD—Fluoropyrimidine Activity—TP53—cervical cancer	0.000607	0.00999	CbGpPWpGaD
Fluorouracil—PPAT—Fluoropyrimidine Activity—TP53—cervical cancer	0.000607	0.00999	CbGpPWpGaD
Fluorouracil—TYMS—Trans-sulfuration and one carbon metabolism—MTHFR—cervical cancer	0.000598	0.00983	CbGpPWpGaD
Fluorouracil—MTHFR—lymph node—cervical cancer	0.000587	0.00516	CbGeAlD
Fluorouracil—ABCG2—uterine cervix—cervical cancer	0.000584	0.00513	CbGeAlD
Fluorouracil—TYMS—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.000583	0.0096	CbGpPWpGaD
Fluorouracil—ABCC4—female gonad—cervical cancer	0.000564	0.00496	CbGeAlD
Fluorouracil—SLC22A7—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.000563	0.00927	CbGpPWpGaD
Fluorouracil—CYP2C8—renal system—cervical cancer	0.000562	0.00494	CbGeAlD
Fluorouracil—Anaemia—Topotecan—cervical cancer	0.00056	0.0155	CcSEcCtD
Fluorouracil—ABCG2—decidua—cervical cancer	0.000557	0.00489	CbGeAlD
Fluorouracil—CYP2C8—endometrium—cervical cancer	0.000543	0.00478	CbGeAlD
Fluorouracil—Leukopenia—Topotecan—cervical cancer	0.000543	0.015	CcSEcCtD
Fluorouracil—TYMP—Bladder Cancer—EGFR—cervical cancer	0.000542	0.00892	CbGpPWpGaD
Fluorouracil—TYMS—lymph node—cervical cancer	0.000536	0.00471	CbGeAlD
Fluorouracil—ABCG2—endometrium—cervical cancer	0.000528	0.00464	CbGeAlD
Fluorouracil—CYP1A2—renal system—cervical cancer	0.000526	0.00462	CbGeAlD
Fluorouracil—ABCC5—lymph node—cervical cancer	0.000523	0.0046	CbGeAlD
Fluorouracil—Myalgia—Topotecan—cervical cancer	0.000516	0.0143	CcSEcCtD
Fluorouracil—Chest pain—Topotecan—cervical cancer	0.000516	0.0143	CcSEcCtD
Fluorouracil—ABCG2—mammalian vulva—cervical cancer	0.000511	0.00449	CbGeAlD
Fluorouracil—Discomfort—Topotecan—cervical cancer	0.00051	0.0141	CcSEcCtD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—GP6—cervical cancer	0.0005	0.00823	CbGpPWpGaD
Fluorouracil—Anaphylactic shock—Topotecan—cervical cancer	0.000495	0.0137	CcSEcCtD
Fluorouracil—Infection—Topotecan—cervical cancer	0.000492	0.0136	CcSEcCtD
Fluorouracil—ABCG2—uterus—cervical cancer	0.000487	0.00428	CbGeAlD
Fluorouracil—Nervous system disorder—Topotecan—cervical cancer	0.000485	0.0134	CcSEcCtD
Fluorouracil—Thrombocytopenia—Topotecan—cervical cancer	0.000484	0.0134	CcSEcCtD
Fluorouracil—ABCC3—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.000483	0.00794	CbGpPWpGaD
Fluorouracil—SLC29A1—lymph node—cervical cancer	0.000481	0.00422	CbGeAlD
Fluorouracil—ABCG2—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.000476	0.00783	CbGpPWpGaD
Fluorouracil—Anorexia—Topotecan—cervical cancer	0.000472	0.0131	CcSEcCtD
Fluorouracil—ABCG2—HIF-1-alpha transcription factor network—CA9—cervical cancer	0.000471	0.00775	CbGpPWpGaD
Fluorouracil—TYMP—Bladder Cancer—TP53—cervical cancer	0.000455	0.00749	CbGpPWpGaD
Fluorouracil—ABCC4—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.000454	0.00747	CbGpPWpGaD
Fluorouracil—Musculoskeletal discomfort—Topotecan—cervical cancer	0.000451	0.0125	CcSEcCtD
Fluorouracil—CYP2C8—female reproductive system—cervical cancer	0.00045	0.00396	CbGeAlD
Fluorouracil—Paraesthesia—Topotecan—cervical cancer	0.000444	0.0123	CcSEcCtD
Fluorouracil—Dyspnoea—Topotecan—cervical cancer	0.000441	0.0122	CcSEcCtD
Fluorouracil—ABCC3—lymph node—cervical cancer	0.000439	0.00386	CbGeAlD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—GP5—cervical cancer	0.000437	0.00719	CbGpPWpGaD
Fluorouracil—Dyspepsia—Topotecan—cervical cancer	0.000435	0.0121	CcSEcCtD
Fluorouracil—TYMP—Fluoropyrimidine Activity—TP53—cervical cancer	0.000433	0.00712	CbGpPWpGaD
Fluorouracil—CYP2A6—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.000432	0.00711	CbGpPWpGaD
Fluorouracil—Decreased appetite—Topotecan—cervical cancer	0.00043	0.0119	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Topotecan—cervical cancer	0.000427	0.0118	CcSEcCtD
Fluorouracil—Pain—Topotecan—cervical cancer	0.000423	0.0117	CcSEcCtD
Fluorouracil—Feeling abnormal—Topotecan—cervical cancer	0.000408	0.0113	CcSEcCtD
Fluorouracil—CYP2C8—vagina—cervical cancer	0.000407	0.00358	CbGeAlD
Fluorouracil—CYP2C9—female reproductive system—cervical cancer	0.0004	0.00351	CbGeAlD
Fluorouracil—ABCG2—female gonad—cervical cancer	0.000398	0.0035	CbGeAlD
Fluorouracil—ABCG2—vagina—cervical cancer	0.000396	0.00348	CbGeAlD
Fluorouracil—Urticaria—Topotecan—cervical cancer	0.000393	0.0109	CcSEcCtD
Fluorouracil—Body temperature increased—Topotecan—cervical cancer	0.000391	0.0108	CcSEcCtD
Fluorouracil—SLC29A1—Fluoropyrimidine Activity—TP53—cervical cancer	0.000375	0.00617	CbGpPWpGaD
Fluorouracil—ALB—lymph node—cervical cancer	0.000375	0.00329	CbGeAlD
Fluorouracil—Hypersensitivity—Topotecan—cervical cancer	0.000365	0.0101	CcSEcCtD
Fluorouracil—ABCC4—lymph node—cervical cancer	0.000363	0.00319	CbGeAlD
Fluorouracil—TYMS—Circadian rythm related genes—UBE3A—cervical cancer	0.000353	0.00581	CbGpPWpGaD
Fluorouracil—Pruritus—Topotecan—cervical cancer	0.00035	0.00969	CcSEcCtD
Fluorouracil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000344	0.00566	CbGpPWpGaD
Fluorouracil—Diarrhoea—Topotecan—cervical cancer	0.000339	0.00937	CcSEcCtD
Fluorouracil—ABCG2—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.000333	0.00548	CbGpPWpGaD
Fluorouracil—Dizziness—Topotecan—cervical cancer	0.000327	0.00906	CcSEcCtD
Fluorouracil—Vomiting—Topotecan—cervical cancer	0.000315	0.00871	CcSEcCtD
Fluorouracil—Rash—Topotecan—cervical cancer	0.000312	0.00864	CcSEcCtD
Fluorouracil—Dermatitis—Topotecan—cervical cancer	0.000312	0.00863	CcSEcCtD
Fluorouracil—Headache—Topotecan—cervical cancer	0.00031	0.00858	CcSEcCtD
Fluorouracil—CYP2A6—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.000302	0.00498	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.0003	0.00494	CbGpPWpGaD
Fluorouracil—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000294	0.00484	CbGpPWpGaD
Fluorouracil—Nausea—Topotecan—cervical cancer	0.000294	0.00814	CcSEcCtD
Fluorouracil—MTHFR—Fluoropyrimidine Activity—TP53—cervical cancer	0.000286	0.0047	CbGpPWpGaD
Fluorouracil—CYP1A2—Tryptophan metabolism—UBE3A—cervical cancer	0.000283	0.00466	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—CA9—cervical cancer	0.000279	0.0046	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—CA9—cervical cancer	0.00026	0.00427	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—CA9—cervical cancer	0.00026	0.00427	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—SERPIND1—cervical cancer	0.000258	0.00424	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—GP6—cervical cancer	0.000258	0.00424	CbGpPWpGaD
Fluorouracil—ABCG2—lymph node—cervical cancer	0.000256	0.00225	CbGeAlD
Fluorouracil—ABCC5—Fluoropyrimidine Activity—TP53—cervical cancer	0.000249	0.00409	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—GP6—cervical cancer	0.000226	0.00372	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—GP5—cervical cancer	0.000225	0.00371	CbGpPWpGaD
Fluorouracil—TYMS—Fluoropyrimidine Activity—TP53—cervical cancer	0.000221	0.00364	CbGpPWpGaD
Fluorouracil—SLC22A7—Fluoropyrimidine Activity—TP53—cervical cancer	0.000214	0.00352	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—GP5—cervical cancer	0.000198	0.00326	CbGpPWpGaD
Fluorouracil—ABCG2—HIF-1-alpha transcription factor network—TERT—cervical cancer	0.000191	0.00314	CbGpPWpGaD
Fluorouracil—ABCC3—Fluoropyrimidine Activity—TP53—cervical cancer	0.000183	0.00302	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—CA9—cervical cancer	0.00018	0.00296	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—CA9—cervical cancer	0.00018	0.00296	CbGpPWpGaD
Fluorouracil—ABCC4—Fluoropyrimidine Activity—TP53—cervical cancer	0.000172	0.00284	CbGpPWpGaD
Fluorouracil—MTHFR—Folate Metabolism—TP53—cervical cancer	0.000164	0.0027	CbGpPWpGaD
Fluorouracil—CYP1A2—Estrogen Receptor Pathway—STAT3—cervical cancer	0.000151	0.00248	CbGpPWpGaD
Fluorouracil—ALB—Vitamin B12 Metabolism—MTHFR—cervical cancer	0.000145	0.00239	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—CA9—cervical cancer	0.000128	0.00211	CbGpPWpGaD
Fluorouracil—ABCG2—Fluoropyrimidine Activity—TP53—cervical cancer	0.000126	0.00208	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.000125	0.00206	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—MTHFR—cervical cancer	0.000118	0.00194	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—SERPIND1—cervical cancer	0.000117	0.00192	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—GP6—cervical cancer	0.000117	0.00192	CbGpPWpGaD
Fluorouracil—CYP2A6—Fluoropyrimidine Activity—TP53—cervical cancer	0.000115	0.00189	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—MTHFR—cervical cancer	0.000113	0.00186	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000112	0.00184	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—WNT2—cervical cancer	0.000107	0.00176	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—MTHFR—cervical cancer	0.000105	0.00173	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—MTHFR—cervical cancer	0.000105	0.00173	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—GP5—cervical cancer	0.000102	0.00168	CbGpPWpGaD
Fluorouracil—TYMS—Retinoblastoma (RB) in Cancer—TP53—cervical cancer	0.000102	0.00168	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—MTHFR—cervical cancer	9.37e-05	0.00154	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—WNT2—cervical cancer	9.31e-05	0.00153	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	8.48e-05	0.00139	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—CA9—cervical cancer	8.46e-05	0.00139	CbGpPWpGaD
Fluorouracil—ABCC4—Ectoderm Differentiation—CTNNB1—cervical cancer	8.25e-05	0.00136	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	8.17e-05	0.00134	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—WNT5A—cervical cancer	8.11e-05	0.00133	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—CA9—cervical cancer	7.37e-05	0.00121	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—MTHFR—cervical cancer	7.3e-05	0.0012	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—MTHFR—cervical cancer	7.3e-05	0.0012	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—WNT5A—cervical cancer	7.06e-05	0.00116	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—CA9—cervical cancer	6.56e-05	0.00108	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	6.47e-05	0.00107	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—TERT—cervical cancer	6.18e-05	0.00102	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	5.44e-05	0.000894	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—CA9—cervical cancer	5.43e-05	0.000893	CbGpPWpGaD
Fluorouracil—TYMS—Circadian rythm related genes—TP53—cervical cancer	5.22e-05	0.000858	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—MTHFR—cervical cancer	5.2e-05	0.000856	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	4.98e-05	0.000819	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	4.98e-05	0.000819	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—HES1—cervical cancer	4.67e-05	0.000768	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—TP53—cervical cancer	4.48e-05	0.000737	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—TERT—cervical cancer	4.09e-05	0.000673	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—HES1—cervical cancer	4.06e-05	0.000668	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—FGFR3—cervical cancer	3.75e-05	0.000617	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CA9—cervical cancer	3.74e-05	0.000616	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MTHFR—cervical cancer	3.57e-05	0.000587	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—TERT—cervical cancer	3.56e-05	0.000586	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—NOTCH1—cervical cancer	3.52e-05	0.00058	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CA9—cervical cancer	3.4e-05	0.00056	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—FGFR3—cervical cancer	3.27e-05	0.000537	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—NOTCH1—cervical cancer	3.07e-05	0.000505	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—MTHFR—cervical cancer	2.99e-05	0.000492	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—MTHFR—cervical cancer	2.66e-05	0.000438	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—MTOR—cervical cancer	2.64e-05	0.000434	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CD4—cervical cancer	2.63e-05	0.000433	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—TP53—cervical cancer	2.35e-05	0.000387	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CTNNB1—cervical cancer	2.34e-05	0.000385	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CA9—cervical cancer	2.32e-05	0.000382	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CA9—cervical cancer	2.31e-05	0.00038	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MTOR—cervical cancer	2.3e-05	0.000378	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CD4—cervical cancer	2.29e-05	0.000377	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—MTHFR—cervical cancer	2.2e-05	0.000363	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—STAT3—cervical cancer	2.04e-05	0.000336	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CTNNB1—cervical cancer	2.04e-05	0.000335	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—TP53—cervical cancer	1.94e-05	0.000319	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CA9—cervical cancer	1.89e-05	0.000311	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—EGFR—cervical cancer	1.85e-05	0.000305	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—STAT3—cervical cancer	1.78e-05	0.000292	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CA9—cervical cancer	1.62e-05	0.000266	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—EGFR—cervical cancer	1.61e-05	0.000266	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—MTHFR—cervical cancer	1.52e-05	0.00025	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—MTHFR—cervical cancer	1.38e-05	0.000227	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—MTHFR—cervical cancer	9.43e-06	0.000155	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—MTHFR—cervical cancer	9.38e-06	0.000154	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TP53—cervical cancer	8.78e-06	0.000144	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—MTHFR—cervical cancer	7.67e-06	0.000126	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—MTHFR—cervical cancer	6.56e-06	0.000108	CbGpPWpGaD
